Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$426,564
+$48,944 QoQ
Shares Held
31,574
+4.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MAI Capital Management holds $12,062,659 across 49 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
78,883 | $9,324,759 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,060 | $628,558 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
4,242 | $558,841 | |
| 4 | VTRS |
Viatris Inc
This page
|
31,574 | $426,564 | |
| 5 | HLN |
Haleon plc
|
19,682 | $197,016 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
2,532 | $194,710 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
9,014 | $125,294 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
3,235 | $106,981 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $426,564 | 31,574 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $377,620 | 30,331 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $322,641 | 32,590 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $254,567 | 28,507 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $242,312 | 27,820 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $345,076 | 27,717 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $308,349 | 26,559 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,025,720 | 96,493 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,495,198 | 125,226 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,396,907 | 128,985 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,762,327 | 178,735 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,661,101 | 166,443 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,574,130 | 163,631 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,255,118 | 112,769 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $320,045 | 37,564 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $381,767 | 36,463 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $202,237 | 18,588 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $231,890 | 17,139 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $225,350 | 16,631 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $257,848 | 18,044 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $258,179 | 18,481 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $380,853 | 20,323 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||